Hussein A N Al-Wadei1, Hildegard M Schuller. 1. Experimental Oncology Laboratory, Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA.
Abstract
BACKGROUND: Lung cancer is the leading cause of cancer death worldwide. A diet rich in fruit and vegetables has been shown to reduce the lung cancer risk. However, clinical trials with beta-carotene and retinoids have disappointed, resulted in increased mortality from lung cancer and cardiovascular disease. METHODS: We have investigated the effects of the two major retinol metabolites, 9-cis-retinoic acid (9-Cis-RA), and 13-cis-retinoic acid (13-Cis-RA), on cell proliferation (MTT assays), intracellular cAMP (cAMP immunoassays), PKA activation (non-radioactive PKA activation assays), and ERK1/2 phosphorylation (Western blots) in immortalized human small airway epithelial cells, HPL1D, a human lung adenocarcinoma cell line, NCI-H322, immortalized human bronchial epithelial cells, BEAS-2B, and in the human small cell lung carcinoma cell line, NCI-H69. RESULTS: Both retinoids increased intracellular cAMP and PKA activation in all cell lines. In BEAS-2B and NCI-H69 cells, the stimulation of cAMP/PKA reduced the phosphorylation of ERK1/2 and inhibited cell proliferation whereas phosphorylation of ERK1/2 and cell proliferation were increased in HPL1D and NCI-H322 cells. CONCLUSIONS: Our data have identified a novel mechanism of action of 9-Cis-RA and 13-Cis-RA: activation of PKA in response to increased cAMP. The observed stimulation of cAMP/PKA may inhibit the development of small cell lung carcinoma and other tumors derived from large airway epithelia whereas it may selectively promote the development of lung tumors derived from small airway epithelial cells, such as adenocarcinoma.
BACKGROUND:Lung cancer is the leading cause of cancer death worldwide. A diet rich in fruit and vegetables has been shown to reduce the lung cancer risk. However, clinical trials with beta-carotene and retinoids have disappointed, resulted in increased mortality from lung cancer and cardiovascular disease. METHODS: We have investigated the effects of the two major retinol metabolites, 9-cis-retinoic acid (9-Cis-RA), and 13-cis-retinoic acid (13-Cis-RA), on cell proliferation (MTT assays), intracellular cAMP (cAMP immunoassays), PKA activation (non-radioactive PKA activation assays), and ERK1/2 phosphorylation (Western blots) in immortalized human small airway epithelial cells, HPL1D, a humanlung adenocarcinoma cell line, NCI-H322, immortalized human bronchial epithelial cells, BEAS-2B, and in the humansmall cell lung carcinoma cell line, NCI-H69. RESULTS: Both retinoids increased intracellular cAMP and PKA activation in all cell lines. In BEAS-2B and NCI-H69 cells, the stimulation of cAMP/PKA reduced the phosphorylation of ERK1/2 and inhibited cell proliferation whereas phosphorylation of ERK1/2 and cell proliferation were increased in HPL1D and NCI-H322 cells. CONCLUSIONS: Our data have identified a novel mechanism of action of 9-Cis-RA and 13-Cis-RA: activation of PKA in response to increased cAMP. The observed stimulation of cAMP/PKA may inhibit the development of small cell lung carcinoma and other tumors derived from large airway epithelia whereas it may selectively promote the development of lung tumors derived from small airway epithelial cells, such as adenocarcinoma.
Authors: M C Copin; L Devisme; M P Buisine; C H Marquette; A Wurtz; J P Aubert; B Gosselin; N Porchet Journal: Int J Cancer Date: 2000-04-15 Impact factor: 7.396
Authors: M E Garber; O G Troyanskaya; K Schluens; S Petersen; Z Thaesler; M Pacyna-Gengelbach; M van de Rijn; G D Rosen; C M Perou; R I Whyte; R B Altman; P O Brown; D Botstein; I Petersen Journal: Proc Natl Acad Sci U S A Date: 2001-11-13 Impact factor: 11.205
Authors: Anthony B Miller; Hans-Peter Altenburg; Bas Bueno-de-Mesquita; Hendriek C Boshuizen; Antonio Agudo; Franco Berrino; Inger Torhild Gram; Lars Janson; Jacob Linseisen; Kim Overvad; Torgney Rasmuson; Paolo Vineis; Annekatrin Lukanova; Naomi Allen; Pilar Amiano; Aurelio Barricarte; Göran Berglund; Heiner Boeing; Françoise Clavel-Chapelon; Nicholas E Day; Göran Hallmans; Eiliv Lund; Carmen Martinez; Carmen Navarro; Domenico Palli; Salvatore Panico; Petra H M Peeters; José Ramón Quirós; Anne Tjønneland; Rosario Tumino; Antonia Trichopoulou; Dimitrios Trichopoulos; Nadia Slimani; Elio Riboli; Dominico Palli Journal: Int J Cancer Date: 2004-01-10 Impact factor: 7.396
Authors: Stephanie A Smith-Warner; Donna Spiegelman; Shiaw-Shyuan Yaun; Demetrius Albanes; W Lawrence Beeson; Piet A van den Brandt; Diane Feskanich; Aaron R Folsom; Gary E Fraser; Jo L Freudenheim; Edward Giovannucci; R Alexandra Goldbohm; Saxon Graham; Lawrence H Kushi; Anthony B Miller; Pirjo Pietinen; Thomas E Rohan; Frank E Speizer; Walter C Willett; David J Hunter Journal: Int J Cancer Date: 2003-12-20 Impact factor: 7.396
Authors: Hannah K Weir; Michael J Thun; Benjamin F Hankey; Lynn A G Ries; Holly L Howe; Phyllis A Wingo; Ahmedin Jemal; Elizabeth Ward; Robert N Anderson; Brenda K Edwards Journal: J Natl Cancer Inst Date: 2003-09-03 Impact factor: 13.506